The classification of tumours of the pituitary gland has recently been revised in the 2021 5th
edition World Health Organization (WHO) Classification of Central Nervous System Tumours …

Today, it becomes essential to develop computer vision algorithms that are both highly
effective and cost-effective for supporting physicians' decisions. Convolutional Neural …

Although pituitary neuroendocrine tumors (PitNETs) are usually benign, some are highly
invasive and recurrent. Recurrent PitNETs are often treatmentresistant and there is …

Simple Summary Few therapies are available for patients with aggressive or metastatic
pituitary neuroendocrine tumours (PitNETs). Peptide receptor radionuclide therapy (PRRT) …

Non-functioning pituitary adenomas (NFPAs) comprise silent tumors of different pituitary
lineages that tend to escape early detection and present as invasive macroadenomas with …

Objectives Pituitary adenomas can exhibit aggressive behavior, characterized by rapid
growth, resistance to conventional treatment, and early recurrence. This study aims to …

Pituitary neuroendocrine tumors (PitNETs) are the most common pituitary tumors and the
second most common brain tumors. Although the vast majority (> 90%) are benign, a small …

Abstract Background Pituitary neuroendocrine tumors (PitNETs) are common gland
neoplasms demonstrating distinctive transcription factors. Although the role of immune cells …

Objective This article reviews the presenting features, molecular characteristics, diagnosis,
and management of selected skull base tumors, including meningiomas, vestibular …

Clinically non functioning pituitary adenomas (NFPAs) include all pituitary adenomas that
are not hormonally active. They are not associated with clinical syndromes such as …